Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Background The epidemiology and long-term healthcare utilisation associated with chronic kidney disease (CKD) among those ...
Cardiovascular disease (CVD) remains one of the leading causes of mortality in England, with its burden disproportionately ...
Atrial fibrillation (AF) is a common arrhythmia associated with increased risk of stroke, heart failure and mortality. Advances in genomic research have revealed a complex genetic architecture ...
Objective Severe secondary tricuspid regurgitation (STR) causes significant right atrial (RA) volume overload, resulting in structural and functional RA-remodelling. This study evaluated whether ...
2 The National Center for Chronic and Noncommunicable Disease Control and Prevention, Beijing, China Objective To examine cardiovascular disease (CVD) mortality burden attributable to ambient ...
Background Optimisation of medical therapy is recommended for patients with newly diagnosed non-ischaemic cardiomyopathies (NICM) before consideration of a primary preventive implantable ...
In the early 2000s, the natural history of heart failure (HF) was vividly illustrated, highlighting a defining feature of HF progression: a prolonged course of fluctuating yet steadily worsening ...
Eosinophil-mediated endomyocardial damage is a well-known complication in patients with hypereosinophilic syndromes (HES). Although management and survival have improved significantly, some patients ...
Objective We aimed to assess differences in incidence, clinical features, current treatment strategies and outcome in patients with type 2 vs. type 1 acute myocardial infarction (AMI). Methods and ...
Objective To describe patterns of prehospital ECG (PHECG) use and determine its association with processes and outcomes of care in patients with ST-elevation myocardial infarction (STEMI) and ...
Correspondence to: Ramachandran S Vasan, MD, Framingham Heart Study, 73, Mt Wayte Avenue, Framingham, MA 01702, USA; vasan{at}fram.nhlbi.nih.gov ...